Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

NYU Langone Medical Center Release: Company Roots Of Related Genetic Diseases Found In Cell Powerhouses

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingNYU Langone Medical Center Release: Company Roots Of Related Genetic Diseases Found In Cell Powerhouses

CBER Publishes 2017 Guidance Agenda

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:Drug Industry Daily

CBER released a set of guidance topics that the center is considering for development this year, covering blood and blood components, tissues and advanced therapies, and chemistry, manufacturing and controls…

Continue ReadingCBER Publishes 2017 Guidance Agenda

Meeting Planner

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:Drug Industry Daily

Source: Drug Industry Daily

Continue ReadingMeeting Planner

Inadequate Written Procedures Land Warner Chilcott a Form 483

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:Drug Industry Daily

Drug manufacturer Warner Chilcott was handed a Form 483 after an inspection revealed inadequate written procedures and deficient cleaning and maintenance of equipment. Source: Drug Industry Daily

Continue ReadingInadequate Written Procedures Land Warner Chilcott a Form 483

HHS Relaxes Proposed Common Rule Restrictions on Biospecimen Research

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:Drug Industry Daily

HHS backed down from implementing its more controversial provisions in a broad overhaul of its Common Rule, including requiring researchers to obtain written consent before testing a donor’s biospecimens, even…

Continue ReadingHHS Relaxes Proposed Common Rule Restrictions on Biospecimen Research

Congress Receives FDA’s User Fee Reauthorization Recommendations

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:Drug Industry Daily

The HHS secretary recently delivered FDA’s recommendations for reauthorizing user fees covering prescriptions, generic drugs and biosimilars to Congress, before the body begins to craft a legislation package due by…

Continue ReadingCongress Receives FDA’s User Fee Reauthorization Recommendations

Precision Interconnect Cited for Poor Documentation

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:The GMP Letter

Precision Interconnect was hit with a Form 483 for poor corrective and preventive action (CAPA) procedures and failing to ensure that products conformed to requirements. Source: The GMP Letter

Continue ReadingPrecision Interconnect Cited for Poor Documentation

Lack of Corrective Action Procedures Earn Hansen Ophthalmic Form 483

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:The GMP Letter

Hansen Ophthalmic Development Lab, Inc., received a Form 483 for not establishing procedures for corrective and preventive action, and for not maintaining a complete device history record. Source: The GMP…

Continue ReadingLack of Corrective Action Procedures Earn Hansen Ophthalmic Form 483

Panoramic Corp. Gets Form 483 for Reporting Failures

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:The GMP Letter

Panoramic Corp. received a Form 483 for not reporting a correction and removal to the FDA and failing to submit medical device reports (MDRs). Source: The GMP Letter

Continue ReadingPanoramic Corp. Gets Form 483 for Reporting Failures

Inservco Inc. Receives Form 483 Citing Procedures, Device History

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:The GMP Letter

Inservco Inc. received a Form 483 for not establishing a complaint handling procedure, failing to properly maintain device history records, and other violations. Source: The GMP Letter

Continue ReadingInservco Inc. Receives Form 483 Citing Procedures, Device History
  • Go to the previous page
  • 1
  • …
  • 581
  • 582
  • 583
  • 584
  • 585
  • 586
  • 587
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.